APA (7th ed.) Citation

Pohl, O. (2018). OBE022, an Oral and Selective Prostaglandin F2{alpha} Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor [Drug Discovery and Translational Medicine]. The American Society for Pharmacology and Experimental Therapeutics.

Chicago Style (17th ed.) Citation

Pohl, O. OBE022, an Oral and Selective Prostaglandin F2{alpha} Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor [Drug Discovery and Translational Medicine]. The American Society for Pharmacology and Experimental Therapeutics, 2018.

MLA (9th ed.) Citation

Pohl, O. OBE022, an Oral and Selective Prostaglandin F2{alpha} Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor [Drug Discovery and Translational Medicine]. The American Society for Pharmacology and Experimental Therapeutics, 2018.